PALLEIKO BENJAMIN L (CFO and Secretary) sold 1.7% of their position (7.29K shares) of KALVISTA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $120.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/9/2025ACC: 0001366244-25-000007
Officer· CFO and Secretary
Since Sep 2018
-7.29K
Net shares
Net seller
$120.4K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
15.63K acquired · 22.92K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+15.63K
Price / share
—
Trade value
—
% of position
3.8%
12/6/2025
416.19K→431.81K
Common Stock
Direct
Shares
−7.29K
Price / share
$16.51
Trade value
$120.42K
% of position
1.7%
12/8/2025
431.81K→424.52K
Total
Net shares
+8.33K
Net value
-$120.42K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/6/2025 | M · Option Exercise | +15.63K | — | — | 3.8% | 416.19K | 431.81K |
| Common Stock Direct | 12/8/2025 | S · Sale | −7.29K | $16.51 | $120.42K | 1.7% | 431.81K | 424.52K |
| Total | +8.33K | -$120.42K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
15.63K shares
Shares
−15.63K
Strike price
Held after
140.63K
Exercisable
—
12/6/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock15.63K shares | 12/6/2025 | M · Option Exercise | −15.63K | — | 140.63K |